Clashing visions for the March for Science are muddying the event’s message, biomedical funding cuts do not put America first, and a rule restricting research on human embryos needs a revamp.

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.

President Trump’s spending plan — running into opposition from Republicans and Democrats alike — would cut about 20 percent of the roughly $30 billion budget of the U.S. medical research agency.

‘Mini-brains’ created in a dish may reveal autism’s roots and point to treatments, but they do not yet mirror some critical features of a human brain.

Donald Trump’s budget blueprint calls for considerable cuts to science agencies, CRISPR corrects mutations in human embryos, and a documentary highlights the challenges faced by an adult with autism.

Two of the women mistakenly thought they were participating in a clinical trial, as the procedure was advertised on a government-run clinical trial website.

Telehealth services may boost access to care, but they don’t save money, according to a new study.

Many researchers oppose unfettered deregulation of the drug approval process, but welcome more relaxed rules for clinical trials.

Scientists recognize women’s contributions, ‘autism’ can be a strike against a person awaiting organ transplant, and stunning science snapshots show cells, squid and sections of the brain.

Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.